VitalMedix | MedCity News

Topic: VitalMedix

University of Minnesota ramps up effort to commercialize drugs

July 27, 2010 4:44 pm by Thomas Lee | 0 Comments

The University of Minnesota is no Pfizer or Merck. But that doesn’t mean it shouldn’t act more like Big Pharma.The school has begun an ambitious effort to convert its considerable ... Read more

Top bioscience lawmaker calls out the University of Minnesota

July 12, 2010 9:15 am by Thomas Lee | 1 Comments

Rep. Tim Mahoney (D-St. Paul) has good reason to feel a fresh spring in his step these days.He helped pass long overdue tax credits for angel investors and research and ... Read more

University of Minnesota spinoff shoots for modest success with cell device

May 26, 2010 3:37 pm by Thomas Lee | 0 Comments

University of Minnesota tech transfer officials have spoken about the “Big One,” a blockbuster technology that would create or upend an industry while earning the school a hefty return for ... Read more

University of Minnesota taps former pharma executive to run transfer unit

April 30, 2010 3:52 pm by Thomas Lee | 0 Comments

Perhaps they should rename the school the University of MGI Pharma.Reggie Bowerman, a former MGI Pharma executive, recently joined the University of Minnesota’s Office for Technology Commercialization (OTC) as head ... Read more

University of Minnesota is open for business. Are there customers?

March 4, 2010 3:39 pm by Thomas Lee | 1 Comments

Quantity or quality?Like most things in life, that’s not always an either/or question. Most people would prefer both. But as the University of Minnesota starts to shop its intellectual property ... Read more

Upwind Medical Partners to create $8 million early stage fund

March 2, 2010 3:22 pm by Thomas Lee | 2 Comments

Another day, another new local early stage fund.Upwind Medical Partners is launching a $6 million to $8 million early stage fund that will focus on commercializing intellectual property from health ... Read more

Promising biotech start-up VitalMedix Inc. files for Chapter 7

February 24, 2010 6:15 pm by Thomas Lee | 1 Comments

VitalMedix Inc., a promising drug company spun out of the University of Minnesota, has shut down and will liquidate its remaining assets, according to sources and documents filed with U.S. ... Read more

Wisconsin angel credits could snag top Minnesota biotech start-up

February 12, 2010 4:17 pm by Thomas Lee | 2 Comments

Sources say top business and political leaders in Wisconsin, including top Assembly Democrat Peter Barca, are lobbying hard for Miromatrix, which spun out of the University of Minnesota late last ... Read more

Angel investment tax credit in Minnesota: The Burden of Proof

February 10, 2010 6:56 pm by Thomas Lee | 11 Comments

Rep. Ann Lenczewski's opposition to angel credits flies in the face of evidence, experts, and the collective political and business will of Minnesota. ... Read more

Kudos to University of Minnesota tech transfer

December 14, 2009 9:18 pm by Thomas Lee | 4 Comments

Politicians, venture capitalists and entrepreneurs have long criticized the school for inhibiting innovation rather than creating it. But that criticism is getting old, or at least it should be. Under ... Read more

Can Minnesota finally pass an angel investment tax credit? Is this a trick question?

December 10, 2009 7:59 pm by Thomas Lee | 5 Comments

For the past two years, the Minnesota House committee that oversees bioscience development held a special hearing on why Minnesota needs an angel investor tax credit to boost high tech ... Read more

In survival mode, biotech startup VitalMedix leaves Minnesota for Wisconsin

July 10, 2009 4:08 pm by Chris Seper | 3 Comments

The biotech startup VitalMedix, which is developing a drug to protect bodies from severe blood loss, is leaving to take advantage of a Wisconsin tax-credit program. Other companies may follow. ... Read more